Head External Communications Editorial Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Head external communications editorial management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Head External Communications Editorial Management Today - Breaking & Trending Today

Grünenthal Group: Grünenthal acquires testosterone treatment Nebido from Bayer

Grünenthal acquires NebidoTM from Bayer AG for up to € 500 million. The product is expected to add about € 100 million to Grünenthal's EBITDA in 2023.NebidoTM is the gold standard for the treatment ....

United States , Nordrhein Westfalen , Fabia Kehren , Gabriel Baertschi , Boston Area Community Health , Bayer Ag , Grunenthal Group , Head External Communications Editorial Management , Latin America , Clinical Endocrinology , Head External Communications , Gr 252 Nenthal ,

Grünenthal donates 400.000€ and provides pain treatment medicine to Ukraine

Aachen, Germany, 7 March 2022 / News Aktuell – Grünenthal, an international science-driven pharmaceutical. ....

Nordrhein Westfalen , United States , Fabia Kehren , Gabriel Baertschi , University Hospital , Grunenthal Group , Head External Communications Editorial Management , News Aktuell , Red Cross , Action Medeor , Latin America , Head External Communications , Gr 252 Nenthal ,

Grünenthal Group: Grünenthal donates 400.000€ and provides pain treatment medicine to Ukraine

AACHEN, Germany, March 7, 2022 /PRNewswire/ Grünenthal, an international science-driven pharmaceutical company, announced that it has donated 400.000€ to the Red Cross to support humanitarian ....

Nordrhein Westfalen , United States , Fabia Kehren , Gabriel Baertschi , University Hospital , Grunenthal Group , Head External Communications Editorial Management , Red Cross , Action Medeor , Latin America , Head External Communications , Gr 252 Nenthal ,

Grünenthal donates 400.000€ and provides pain treatment medicine to Ukraine

Aachen, Germany, 7 March 2022 –Grünenthal, an international science-driven pharmaceutical company, announced that it has donated 400.000€ to the Red Cross to support humanitarian relief efforts in Ukraine and Eastern Europe. In addition, Grünenthal partners with Action Medeor and the University Hospital of RWTH Aachen to provide urgently needed pain medication to the region. The first transport with medicine is set to leave Aachen this week. “We are shocked and saddened by the attack on Ukraine. Our full solidarity is with Ukraine’s people and everyone affected, no matter where they come from. Grünenthal will contribute to ensuring urgently needed medical care”, said Gabriel Baertschi, CEO of Grünenthal. About Grünenthal Grünenthal is a global leader in pain management and related diseases. As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our ....

Nordrhein Westfalen , United States , Fabia Kehren , Gabriel Baertschi , University Hospital , Grunenthal Group , Head External Communications Editorial Management , Red Cross , Action Medeor , Latin America , Head External Communications ,

Grünenthal donates 400.000€ and provides pain treatment medicine to Ukraine

Aachen, Germany, 7 March 2022 – Grünenthal, an international science-driven pharmaceutical company, announced that it has donated 400.000€ to the Red Cross to support humanitarian reli. ....

Nordrhein Westfalen , United States , Fabia Kehren , Gabriel Baertschi , University Hospital , Grunenthal Group , Head External Communications Editorial Management , Red Cross , Action Medeor , Latin America , Head External Communications ,